Allergen immunotherapy is entering the era of precision medicine. Instead of treating all allergy patients according to the same scheme, doctors can now tailor therapy to an individual’s molecular allergy profile and specific disease mechanisms. Thanks to modern diagnostics and biomarkers, it is becoming possible to distinguish true allergy from cross-reactivity, better predict treatment effectiveness, and improve patient safety. According to Prof. Marek Jutel from Wroclaw Medical University, allergology is moving toward highly personalized causal treatment, although wider implementation still requires further research, standardization, and broader access to advanced diagnostics.

New report from the Partnership for International Vaccine Initiatives Finds Countries with Seasonal Influenza Programs Achieved 2.5× Higher COVID-19 Vaccination Coverage

Protecting old-growth forests significantly boosts soil physical–biochemical quality, dissolved organic matter chemodiversity, and beneficial mycorrhizal fungi, offering a proven pathway to safeguard endangered Ocotea porosa and mitigate climate change.

Chatbots can provide fast, clear answers about symptoms, and a study from Wroclaw Medical University shows they are usually correct. The problem isn’t obvious errors, but partially accurate answers that sound convincing while missing key clinical details.

In conditions like urinary tract stones—where treatment depends on many factors—such simplifications can mislead patients, delay care, or lead to risky self-treatment.

AI can help patients understand a problem and prepare for a doctor’s visit. But it cannot replace medical consultation, where information is assessed in full clinical context.